Showing results (551-560 of 578) with videos related to
Sort By:
Pageof 58
Molecular Cancer Therapeutics|June 5, 2021
Therapeutic Synergy in Esophageal Cancer and Mesothelioma Is Predicted by Dynamic BH3 ProfilingDeborah R Surman, Yuan Xu, Min-Jung Lee, et al.International Journal of Radiation Oncology, Biology, Physics|April 6, 2023
Dosimetric Evaluation of Organs at Risk From SAVE ProtocolJeremy N Kunz, Y Jessica Huang, Anthony C Casper, et al.JCO Global Oncology|February 2, 2021
Cervix Cancer in Sub-Saharan Africa: An Assessment of Cervical Cancer ManagementLindsay M Burt, Mary McCormak, Fabrice Lecuru, et al.Scientific Reports|August 22, 2025
Exposure-inducible genes may contribute to missingness in RNAseq-based gene expression analysesOlga Y Gorlova, Ivan P Gorlov, R Taylor Ripley, et al.Journal of Thoracic Imaging|December 9, 2017
Computed Tomography Features associated With the Eighth Edition TNM Stage Classification for Thymic Epithelial TumorsSukhmani K Padda, Donato Terrone, Lu Tian, et al.BMC Cancer|July 14, 2025
Gene expression in tumor and adjacent normal tissues in lung adenocarcinoma subtypesOlga Y Gorlova, Ivan P Gorlov, R Taylor Ripley, et al.Anesthesia and Analgesia|February 27, 2025
Design and Staged Implementation of a Multidisciplinary Preoperative Anemia Clinic at a Tertiary Care Medical CenterEthan H Crispell, Claire E Cassianni, Jennifer M Burt, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2022
A Phase II Window of Opportunity Study of Neoadjuvant PD-L1 versus PD-L1 plus CTLA-4 Blockade for Patients with Malignant Pleural MesotheliomaHyun-Sung Lee, Hee-Jin Jang, Maheshwari Ramineni, et al.Cancer|July 20, 2016
A phase 1 dose-escalation study of filanesib plus bortezomib and dexamethasone in patients with recurrent/refractory multiple myelomaAjai Chari, Myo Htut, Jeffrey A Zonder, et al.Proceedings. Biological Sciences|March 1, 2005
Menstrual cycle, pregnancy and oral contraceptive use alter attraction to apparent health in facesB C Jones, D I Perrett, A C Little, et al.Pageof 58